Commercial Channels

Home infusion association gathers member data, measuring variations in business practices

PCMA study estimates additional $32 billion in added healthcare costs through 2021; coupons 'lure consumers to switch from generics to expensive brands'

Unifying a company’s approach to marketing fulfillment activities could provide innovation while delivering cost savings

Pharma marketers become adept at refining coupon and voucher programs, while technology options multiply. Meanwhile payer criticism mounts

Following FDA’s punt of regulations for social media, industry is scratching its collective head over how to utilize these channels

Electronic health-record systems (EHRs) are bringing needed drug information to the point of care for prescribers

Nearly 200 drugs now carry requirements for a risk management program, as FDA evaluates the initial follow-up reporting from manufacturers

Combining prescription and OTC purchasing patterns gives deeper insights into patient behavior

First-ever injectable acetaminophen will serve pain sufferers who can’t take pills

MCM is but one way to get a focus on the explosive growth of new communication channels to physicians and patients

Drivers in the post-healthcare-reform world

HealthPrize Technologies is readying a sweepstakes approach to encourage patient compliance

By combining online with traditional direct-marketing media, manufacturers can accelerate sampling programs even in the face of restricted physician access

A biopharma marketer uses direct mail and a call center to access hard-to-reach physicians

Healthcare discussions are booming on the Internet. How will FDA allow pharma to participate?

While staff sales forces continue to shrink, the contract sales business is expected to nearly double over the next five years

50 Years of Birth Control: Pharma Continues to Push for More Reproductive-Health Options

Some healthcare providers are pushing for OTC access to birth control. Pharma appears to be on the sideline in the debate

Consulting and marketing research firm breaks down product brand identity

Business, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?

Multi-tenant sales-force automation (SFA) systems are coping with an increasingly complex regulatory environment

PhRMA pushes for an FDA ‘universal symbol’ of approved content, and seeks latitude in communications in online forums

The Medical Affairs function can play a vital role in today’s product launch process

Over half of all physicians are participating in social-media sites or online professional networks

While researchers study new pain-killing pathways, the pharma industry tries drug combinations and alternative-delivery mechanisms By Angelo DePalma, PhD

In competing for pharmacy business, AmerisourceBergen, Cardinal Health and McKesson offer improved access to branded and generic products

FDA’s requirements for risk evaluation and mitigation challenge both new and existing commercialization processes

The current FDA policy toward REMS is being challenged by Allergan

The basic process of defining customer segments and appropriate promotional messaging benefits from a cross-disciplinary approach